UPDATE: Antares Says FDA Letter Says Deficiencies Preclude Continuation Of Discussions, Doesn't Specify What Deficiencies Are; Co. Expects Further Communications With FDA On Or Before Oct. 20 PDUFA Date
Hal Lindon